The current valuation score of Oragenics Inc is 8.57, ranking 82 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.35, which is -88.95% below the recent high of -0.04 and -1303.27% above the recent low of -4.93.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.